Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin

BACKGROUND: Intratumoral BCG therapy, one of the earliest immunotherapies, can lead to infiltration of immune cells into a treated tumor. However, an increase in the number of BCG-induced tumor-specific T cells in the tumor microenvironment could lead to enhanced therapeutic effects. METHODS: Here,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Ylösmäki, Erkko, Fusciello, Manlio, Martins, Beatriz, Feola, Sara, Hamdan, Firas, Chiaro, Jacopo, Ylösmäki, Leena, Vaughan, Matthew J, Viitala, Tapani, Kulkarni, Prasad S, Cerullo, Vincenzo
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2021
Assuntos:
Oncolytic and Local Immunotherapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8286790/
https://ncbi.nlm.nih.gov/pubmed/34266884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2021-002707
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados